BetterLife Pharma Inc.
BETRF
$0.05
$0.00-6.25%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.76% | 89.63% | 46.34% | 406.18% | -37.57% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -126.10% | -113.60% | -194.26% | -43.17% | 21.16% |
| Change in Net Operating Assets | 162.43% | 180.32% | 151.43% | -186.11% | -54.35% |
| Cash from Operations | 82.85% | 98.42% | 92.86% | 64.32% | -109.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.72% | -- | -- | -91.95% | 151.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.26% | -98.08% | -95.88% | -91.99% | 145.31% |
| Foreign Exchange rate Adjustments | -- | -- | 100.00% | -100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.06% | -97.32% | 81.91% | -438.20% | -54.94% |